Table 2.

Alaskan berry and fungus treatments extend wildtype C. elegans lifespan.

Treatment	N	Mean lifespan ± S.E.M.	Percent of control (%)	p-value	Highest increase observed (%)	Lowest increase observed (%)
Blueberry dose (μg/mL)
0	60	9.48 ± 0.31
60	66	12.4 ± 0.56	130	<0.0001	128	107
100	60	11.2 ± 0.59	118	<0.0001	144	111
200	51	12.4 ± 0.73	130	0.001	147	120
400	58	11.2 ± 0.58	118	<0.0001	139	120
800	60	9.31 ± 0.28	98	0.341	117	109 (n.s.)
Lowbush cranberry dose (μg/mL)
0	50	11.3 ± 0.58
50	50	13.9 ± 0.91	123	0.012	122	116
100	51	11.1 ± 0.50	98	0.868	116	104 (n.s.)
200	50	12.5 ± 0.49	110	0.123	119	106
400	50	13.9 ± 0.89	123	0.016	122	108
800	50	12.5 ± 0.28	110	0.229	119	108 (n.s)
Chaga dose (μg/mL)
0	50	10.7 ± 0.50
50	49	13.1 ± 0.60	122	0.002	122	113
200	50	12.9 ± 0.55	121	0.005	124	117
800	47	12.9 ± 0.65	121	0.003	121	116

Percent change in lifespan relative to control, significance from the representative survival curves shown in Figures 1A–C. The highest and lowest percent increase in lifespan relative to control in all replicates is also reported. Experiments were repeated in multiple independent trials (≥3), all with the same directional effect and similar magnitude of effect. Statistical significance (p-value) calculated with Kaplan-Meier log-rank test.